Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review
International Journal of Dermatology · 2023
DOI: 10.1111/ijd.16844 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Dermatology, 2023. Verfasst von Ariela A Souroujon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Universidad Anahauc México, Huixquilucan, Mexico. Hauptthemen laut MEDLINE: Vitiligo, Pigmentation Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Objective
This systematic review provides a comprehensive analysis of the efficacy of autologous cell transplant as a therapeutic approach for stable segmental vitiligo. Vitiligo poses significant challenges for healthcare professionals in terms of treatment selection. Autologous cell transplant has emerged as a promising modality for managing vitiligo, with cultured and noncultured transplants being considered when determining the patient's treatment approach. There is little knowledge and literature on the subject, so we analyze the different studies.
Method
Using online medical literature databases and the PRISMA guidelines, six out of 60 articles met the acceptance criteria to be analyzed, emphasizing the lack of current literature on this subject.
Results
Autologous cell transplant achieves excellent pigmentation rates for many body parts. We found that cultivated cells had better results than noncultivated ones. Both types of treatments could pigment 80% or more where needed.
Conclusion
This review highlights the importance of autologous cell transplant as a new and reliable tool for the treatment of stable segmental vitiligo, cultured transplants being the most effective. By employing autologous cell transplant, the repigmentation rate is notably high and consistently achievable. Although its cost and logistical complexities hinder the current accessibility to this therapy, efforts are being made to enhance its availability, and its scope is expected to expand further. More studies are needed to understand this therapy method in other kinds of vitiligo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Universidad Anahauc México, Huixquilucan, Mexico.
- Dermatology Clinic Dermacares, Mexico City, Mexico.
ORCID-Profile: Ariela A Souroujon, Ilana Guttman, Nathalie Levin, Galia Capuano, Cesar Alejandro Reyes Salcedo, Paulina García
Zitieren
APA
Souroujon, A. A., Guttman, I., Levin, N., Capuano, G., Reyes Salcedo, C. A., & García, P. (2023). Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review. International Journal of Dermatology. https://doi.org/10.1111/ijd.16844
Vancouver
Souroujon AA, Guttman I, Levin N, Capuano G, Reyes Salcedo CA, García P. Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review. International Journal of Dermatology. 2023. doi:10.1111/ijd.16844
BibTeX
@article{Souroujon2023,
author = {Souroujon, Ariela A and Guttman, Ilana and Levin, Nathalie and Capuano, Galia and Reyes Salcedo, Cesar Alejandro and García, Paulina},
title = {Autologous cell transplant as a treatment for stable segmental vitiligo: a systematic review},
journal = {International Journal of Dermatology},
year = {2023},
doi = {10.1111/ijd.16844}
}
EUVIMED